DEYCX
Price
$16.89
Change
-$0.11 (-0.65%)
Updated
Nov 14 closing price
GFACX
Price
$70.27
Change
-$0.64 (-0.90%)
Updated
Nov 14 closing price
Ad is loading...

DEYCX vs GFACX

Header iconDEYCX vs GFACX Comparison
Open Charts DEYCX vs GFACXBanner chart's image
BNY Mellon Large Cap Equity C
Price$16.89
Change-$0.11 (-0.65%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$70.27
Change-$0.64 (-0.90%)
VolumeN/A
CapitalizationN/A
DEYCX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DEYCX vs. GFACX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEYCX is a StrongBuy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 306B vs. DEYCX (290M). DEYCX (0.00) and GFACX (0.00) have matching dividends . DEYCX was incepted earlier than GFACX: DEYCX (16 years) vs GFACX (24 years). DEYCX is a more actively managed with annual turnover of: 70.46 vs. GFACX (31.00). GFACX has a lower initial minimum investment than DEYCX: GFACX (250) vs DEYCX (1000). GFACX annual gain was more profitable for investors over the last year : 29.12 vs. DEYCX (-7.41). GFACX return over 5 years is better than : 48.44 vs. DEYCX (-17.20).
DEYCXGFACXDEYCX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years24 years-
Gain YTD11.47528.92740%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets290M306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-7.4129.12-25%
Returns for 3 years-44.46-5.45815%
Returns for 5 years-17.2048.44-36%
Returns for 10 years2.5758.854%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSVEX6.18N/A
N/A
Morgan Stanley Vitality Portfolio A
JHBCX65.46N/A
N/A
JHancock Blue Chip Growth NAV
QCACX44.23-0.03
-0.07%
Federated Hermes MDT All Cap Core C
PXIIX21.51-0.03
-0.14%
Virtus KAR Equity Income I
FIQPX50.62-0.42
-0.82%
Fidelity Advisor Emerging Asia Z